Journal List > Korean J Urol > v.50(8) > 1005386

Cha, Lee, Cho, Kang, and Yoo: Efficacy and Safety of Intravenous Propofol Anesthesia during Transrectal Ultrasound-Guided Prostate Biopsy

Abstract

Purpose

Transrectal ultrasonography (TRUS)-guided prostate biopsy causes fear and pain in 65% to 90% of patients. This study was designed to evaluated the use of intravenous propofol anesthesia during TRUS-guided prostate biopsy.

Materials and Methods

Between January 2006 and June 2008, 195 men undergoing a transrectal prostate biopsy were divided into 2 groups according to anesthetic technique. Group A consisted of 99 patients who received intravenous propofol infusion through an 18 gauge needle during TRUS-guided prostate biopsy. Group B consisted of 96 patients who intrarectally received 10 ml of 2% lidocaine gel 10 minutes before TRUS-guided prostate biopsy. Pain scores were assessed on a visual analogue scale immediately after prostate biopsy.

Results

The pain score was significantly reduced in group A compared with group B. There was a significant difference in the mean pain score between the 2 groups (1.0±1.3 in group A versus 2.9±2.0 in group B; p< 0.01). Also, there was a significant difference in the willingness to undergo rebiopsy between the 2 groups (83.8% in group A versus 17.7% in group B; p<0.01). However, the complication rates were not significantly different between the 2 groups. Gross hematuria was found in 14% of group A patients and 18% of group B patients.

Conclusions

Our results proved the advantage of intravenous propofol anesthesia during TRUS-guided prostate biopsy. Intravenous propofol infusion can be a safe and simple technique that significantly reduces pain during TRUS-guided prostate biopsy.

REFERENCES

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000; 50:7–33.
crossref
2. Collins GN, Lloyd SN, Hehir M, McKelvie GB. Multiple transrectal ultrasound-guided prostatic biopsies–true morbidity and patient acceptance. Br J Urol. 1993; 71:460–3.
crossref
3. Aus G, Hermansson CG, Hugosson J, Pedersen KV. Transrectal ultrasound examination of the prostate: complications and acceptance by patients. Br J Urol. 1993; 71:457–9.
crossref
4. Nash PA, Bruce JE, Indudhara R, Shinohara K. Transrectal ultrasound guided prostatic nerve blockade eases systematic needle biopsy of the prostate. J Urol. 1996; 155:607–9.
crossref
5. Irani J, Fournier F, Bon D, Gremmo E, Dore B, Aubert J. Patient tolerance of transrectal ultrasound-guided biopsy of the prostate. Br J Urol. 1997; 79:608–10.
crossref
6. 2002’ Annual reports of Central Cancer Registry Center in Korea. National Cancer Center of Korea.
7. Soloway MS, Obek C. Periprostatic local anesthesia before ultrasound guided prostate biopsy. J Urol. 2000; 163:172–3.
crossref
8. Borboroglu PG, Comer SW, Riffenburgh RH, Amling CL. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol. 2000; 163:158–62.
crossref
9. Aus G, Damber JE, Hugosson J. Prostate biopsy and anaesthesia: an overview. Scand J Urol Nephrol. 2005; 39:124–9.
crossref
10. Patterson KW, Casey PB, Murray JP, O'Boyle CA, Cunningham AJ. Propofol sedation for outpatient upper gastrointestinal endoscopy: comparison with midazolam. Br J Anaesth. 1991; 67:108–11.
crossref
11. Chanvej L, Kijsirikul S, Thongsuksai P, Naheem L. Postoperative nausea and vomiting in outpatient gynecologic laparoscopy: a comparison of thiopental-nitrous oxide, propofol-nitrous oxide and total intravenous anesthesia using propofol. J Med Assoc Thai. 2001; 84:697–704.
12. Beller JP, Pottecher T, Lugnier A, Mangin P, Otteni JC. Prolonged sedation with propofol in ICU patients: recovery and blood concentration changes during periodic interruptions in infusion. Br J Anaesth. 1988; 61:583–8.
crossref
13. Kitamura T, Fujiwara H, Nagata O, Usui H, Suzuki T, Ogawa M, et al. Anesthetic management using propofol and fentanyl for transrectal ultrasound-guided prostatic biopsy. Masui. 2001; 50:1209–12.
14. Peters JL, Thompson AC, McNicholas TA, Hines JE, Hanbury DC, Boustead GB. Increased patient satisfaction from transrectal ultrasonography and biopsy under sedation. BJU Int. 2001; 87:827–30.
crossref
15. Park JY, Park SJ, Choi SU, Shin HW, Lee HW, Lim HJ, et al. Target-controlled propofol infusion for sedation in patients undergoing transrectal ultrasound-guided prostate biopsy. J Int Med Res. 2007; 35:773–80.
crossref
16. Kim KS, Kim JS, Park SW. Study on the effects and safety of propofol anesthesia during cystoscopy. Korean J Urol. 2006; 47:1230–5.
crossref
17. Lee JW, Jeong JY, Yoo TK. Ureteroscopy under intravenous propofol anesthesia for the treatment of middle and upper ureteral calculi: comparison with lower ureteral calculi. Korean J Urol. 2002; 43:738–42.
18. Issa MM, Bux S, Chun T, Petros JA, Labadia AJ, Anastasia K, et al. A randomized prospective trial of intrarectal lidocaine for pain control during transrectal prostate biopsy: the Emory University experience. J Urol. 2000; 164:397–9.
crossref
19. Stirling BN, Shockley KF, Carothers GG, Maatman TJ. Comparison of local anesthesia techniques during transrectal ultrasound-guided biopsies. Urology. 2002; 60:89–92.
crossref
20. Desgrandchamps F, Meria P, Irani J, Desgrippes A, Teillac P, Le Duc A. The rectal administration of lidocaine gel and tolerance of transrectal ultrasonography-guided biopsy of the prostate: a prospective randomized placebo-controlled study. BJU Int. 1999; 83:1007–9.
crossref
21. Wu CL, Carter HB, Naqibuddin M, Fleisher LA. Effect of local anesthetics on patient recovery after transrectal biopsy. Urology. 2001; 57:925–9.
crossref

Fig. 1.
Individual pain assessment by category. Group A: intravenous propofol, Group B: intrarectal lidocaine gel.
kju-50-757f1.tif
Table 1.
Characteristics of the patients
  Group A Group B p-value
No. of patients 99 96  
Age (years) 67.3±9.1 67.8±10.4 0.855
PSA (ng/ml) 14.0±23.2 13.9±21.6 0.979
Prostate volume (ml) 62.7±23.1 63.1±27.2 0.910

PSA: prostate-specific antigen, Group A: intravenous propofol, Group B: intrarectal lidocaine gel

Table 2.
Comparison of results between groups and willingness to undergo prostate rebiopsy
  Group A (n=99) Group B (n=96) p-value
Pain score      
 Mean±SD 1.0±1.3 2.9±2.0 <0.001
 Median (range) 0.8 (0-2.4) 2.8 (0-5.3)  
Biopsy results      
 Adenocarcinoma (%) 36 (36.4) 42 (43.8) 0.267
 Benign pathology (%) 63 (63.6) 54 (56.2) 0.293
 Will of rebiopsy: Yes (%) 83 (83.8) 17 (17.7) <0.001

Group A: intravenous propofol, Group B: intrarectal lidocaine gel

Table 3.
Complications of prostate biopsy
  Group A (37/99) Group B (34/96) p-value
Gross hematuria 14 18 0.385
Dysuria 37 34 0.274
Hemospermia 5 3 0.498
Rectal bleeding 21 19 0.806
Fever 3 1 0.327
Acute urinary retention 2 4 0.386
Vasovagal reaction 6 3 0.718

Group A: intravenous propofol, Group B: intrarectal lidocaine gel

Table 4.
Selection of anesthesia for prostate rebiopsy
  Group A (n=83) Group B (n=17) p-value
Same anesthesia 81 (97.6) 4 (23.5) 0.007
Other anesthesia 2 (2.4) 13 (76.5)

Group A: intravenous propofol, Group B: intrarectal lidocaine gel

TOOLS
Similar articles